Stenl.o slashed.se, Denmark

Svend Aage Hansen

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novo Nordisk A/s. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Svend Aage Hansen. Retrieved from https://idiyas.com/inventor/svend-aage-hansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Svend Aage Hansen: Innovator at Novozymes A/S

Introduction

Svend Aage Hansen is a notable inventor based in Bagsværd, Denmark. He is currently associated with Novozymes A/S, a leading company in the field of biotechnology. Despite having no patents to his name, Hansen's contributions to his field are significant.

Latest Patents

Svend Aage Hansen has not registered any patents as of now. This does not diminish his role in the innovative processes at Novozymes A/S.

Career Highlights

Hansen has built a career focused on biotechnology and its applications in various industries. His work at Novozymes A/S has allowed him to collaborate with other experts in the field, enhancing the company's research and development efforts.

Collaborations

One of his notable coworkers is Peter Rosholm. Together, they contribute to the innovative environment at Novozymes A/S, fostering advancements in biotechnology.

Conclusion

Svend Aage Hansen is an important figure in the biotechnology sector, working diligently at Novozymes A/S. His collaborative efforts and commitment to innovation continue to shape the future of the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…